159 related articles for article (PubMed ID: 28370171)
1. A review on acridinylthioureas and its derivatives: biological and cytotoxic activity.
Kožurková M; Sabolová D; Kristian P
J Appl Toxicol; 2017 Oct; 37(10):1132-1139. PubMed ID: 28370171
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore.
Martins ET; Baruah H; Kramarczyk J; Saluta G; Day CS; Kucera GL; Bierbach U
J Med Chem; 2001 Dec; 44(25):4492-6. PubMed ID: 11728195
[TBL] [Abstract][Full Text] [Related]
3. Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
Guddneppanavar R; Choudhury JR; Kheradi AR; Steen BD; Saluta G; Kucera GL; Day CS; Bierbach U
J Med Chem; 2007 May; 50(9):2259-63. PubMed ID: 17408248
[TBL] [Abstract][Full Text] [Related]
4. Bis(acridinylthiourea)platinum(II) complexes: synthesis, DNA affinity, and biological activity in glioblastoma cells.
Augustus TM; Anderson J; Hess SM; Bierbach U
Bioorg Med Chem Lett; 2003 Mar; 13(5):855-8. PubMed ID: 12617907
[TBL] [Abstract][Full Text] [Related]
5. Gold(I) analogues of a platinum-acridine antitumor agent are only moderately cytotoxic but show potent activity against Mycobacterium tuberculosis.
Eiter LC; Hall NW; Day CS; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2009 Nov; 52(21):6519-22. PubMed ID: 19803526
[TBL] [Abstract][Full Text] [Related]
6. Acridine and acridone derivatives, anticancer properties and synthetic methods: where are we now?
Belmont P; Bosson J; Godet T; Tiano M
Anticancer Agents Med Chem; 2007 Mar; 7(2):139-69. PubMed ID: 17348825
[TBL] [Abstract][Full Text] [Related]
7. Sulfur Containing Acridine Derivatives in Preclinical Studies with Cancer Cell Lines.
Othman S; Kozurkova M
Curr Med Chem; 2018; 25(17):1968-1975. PubMed ID: 28413957
[TBL] [Abstract][Full Text] [Related]
8. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
9. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
10. Acridine and its derivatives: a patent review (2009 - 2013).
Zhang B; Li X; Li B; Gao C; Jiang Y
Expert Opin Ther Pat; 2014 Jun; 24(6):647-64. PubMed ID: 24848259
[TBL] [Abstract][Full Text] [Related]
11. Linker-modified triamine-linked acridine dimers: synthesis and cytotoxicity properties in vitro and in vivo.
Wang SS; Lee YJ; Hsu SC; Chang HO; Yin WK; Chang LS; Chou SY
Bioorg Med Chem; 2007 Jan; 15(2):735-48. PubMed ID: 17107806
[TBL] [Abstract][Full Text] [Related]
12. Effect of linkage geometry on biological activity in thiourea- and guanidine-substituted acridines and platinum-acridines.
Ma Z; Saluta G; Kucera GL; Bierbach U
Bioorg Med Chem Lett; 2008 Jul; 18(13):3799-801. PubMed ID: 18515101
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity of 9-benzylamino-6-chloro-2-methoxy-acridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.
Zhang W; Zhang B; Zhang W; Yang T; Wang N; Gao C; Tan C; Liu H; Jiang Y
Eur J Med Chem; 2016 Jun; 116():59-70. PubMed ID: 27060757
[TBL] [Abstract][Full Text] [Related]
14. Proflavine/acriflavine derivatives with versatile biological activities.
Sabolova D; Kristian P; Kozurkova M
J Appl Toxicol; 2020 Jan; 40(1):64-71. PubMed ID: 31222780
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.
Gao C; Li B; Zhang B; Sun Q; Li L; Li X; Chen C; Tan C; Liu H; Jiang Y
Bioorg Med Chem; 2015 Apr; 23(8):1800-7. PubMed ID: 25778766
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity and structure-activity relationships between ester and amide functionalities in novel acridine-based platinum(II) complexes.
Bouyer F; Moretto J; Pertuit D; Szollosi A; Lacaille-Dubois MA; Blache Y; Chauffert B; Desbois N
J Inorg Biochem; 2012 May; 110():51-7. PubMed ID: 22459174
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships in platinum-acridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity.
Ackley MC; Barry CG; Mounce AM; Farmer MC; Springer BE; Day CS; Wright MW; Berners-Price SJ; Hess SM; Bierbach U
J Biol Inorg Chem; 2004 Jun; 9(4):453-61. PubMed ID: 15067524
[TBL] [Abstract][Full Text] [Related]
19. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
[TBL] [Abstract][Full Text] [Related]
20. Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine. Synthesis, antitumor activity, and DNA binding.
Bouffier L; Baldeyrou B; Hildebrand MP; Lansiaux A; David-Cordonnier MH; Carrez D; Croisy A; Renaudet O; Dumy P; Demeunynck M
Bioorg Med Chem; 2006 Nov; 14(22):7520-30. PubMed ID: 16879973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
